Navigation Links


IRIDEX to Report First Quarter 2017 Financial Results on May 3, 2017

4/19/2017
MOUNTAIN VIEW, Calif. , April 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ) today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3, 2017.  The Company's management team will host a corresponding conference call beginning at 2:30 p.m. PT / 5:30 p.m. ET. Investors interested in listening to the... [Comments]

Surgical Drainage Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

4/19/2017
NEW YORK , April 19, 2017 Global Surgical Drainage Device Market: Overview Surgical drainage devices are tubes used to remove excess liquid and air. The fluid to be drained may include, blood, serum, pus, urine, bile or lymph. Surgical drains are used in a wide variety of different types of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic s... [Comments]

Prostate Cancer Therapeutics Market ; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

4/19/2017
NEW YORK , April 19, 2017 Global Prostate Cancer Therapeutics Market: Overview This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate cancer, launch of promising emerging therapies, as well as innovation in the development of new drugs & therapeutic biological products, and... [Comments]

First patients at Vanderbilt University Medical Center implanted in EndoStim's LESS GERD clinical trial for gastroesophageal reflux disease (GERD)

4/19/2017
NASHVILLE , Tenn. and DALLAS , April 19, 2017  Vanderbilt University Medical Center (VUMC) and EndoStim, Inc., announced that the first patients in Nashville , Tennesse have been implanted with the EndoStim device in the Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim system is a minimally-invasive implantable device designed to p... [Comments]

Effective Microorganisms (EM) Market Sales, Revenue and Industry Growth Rate 2017-2022, Available at ReportsnReports.com

4/19/2017
PUNE, India , April 19, 2017 The Global Effective Microorganisms (EM) Market by Manufacturers, Countries, Type and Application, Forecast to 2022 report has covered and analysed the potential of Global Effective Microorganisms (EM) Market and provides statistics and information on market size, shares and growth factors. The report identifies and analyses the emerging trends a... [Comments]

Sorrento Announces Closing of Public Offering of Common Stock

4/19/2017
SAN DIEGO , April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, today announced the closing of its previously announced underwritten public offering of 23,625,084 shares of its common stock at a public offering price of $... [Comments]

Companion Animal Vaccines Market: Canine Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

4/19/2017
LONDON , April 19, 2017 Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live vaccines are derived from disea... [Comments]

150-year-old Drug May Provide 'Off' Time Relief for People with Advanced Parkinson's Disease

4/19/2017
BOSTON , April 19, 2017  New research provides evidence that an old drug may provide relief for people with advanced Parkinson's, according to a study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston , April 22 to 28, 2017. When it comes to the treatment of Parkinson's disease, the oral drug levod... [Comments]

NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia

4/19/2017
EAST HANOVER, N.J. , April 19, 2017  Novartis today announced the publication of a study conducted by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) demonstrating that 58% of patients with treatment-naïve severe aplastic anemia (SAA) achieved complete response at six months when treated with eltrombopag at the initiation of... [Comments]

Atara Biotherapeutics, Inc. Leases First of Nine Buildings Underway in Conejo Spectrum by SRG Commercial

4/19/2017
THOUSAND OAKS, Calif. , April 19, 2017  SARES•REGIS Group leased the first of nine premium industrial buildings it is developing at Conejo Spectrum Business Park in Thousand Oaks, California , to Atara Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by... [Comments]

[previous] [next]
(Date:4/25/2017)... SCOTTSDALE, Ariz. (PRWEB) , ... April 25, 2017 , ... ... the latest book of the Outlier Leadership Series, Outliers in Writing, set to publish ... and Professor of Emergency Medicine at the University of Arizona College of Medicine. He ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
(Date:4/24/2017)... TN (PRWEB) , ... April 24, 2017 , ... Michael ... fans and transforming the quarterback position. The former overall number one pick in the ... professional football career. He holds the record for the most career rushing yards by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a ... new strategies to reduce waste, and support renewable energy. They believe this is a ... nature to find solutions for health issues, and maintain that destroying the environment in ...
Breaking Medicine News(10 mins):
... mm. Grooved buckle. Size: 2.3 x 4.0 x ... Scleral Sponge II line designed by Harvey A. ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
... 5.0 x 80 mm. Storz offers ... designed by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... Size: 7.5 x 2.75 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
Medicine Products:
(Date:4/19/2017)... 2017 Companion animal ... in pets such as canine, avian and feline. ... types such as Attenuated Live Vaccines, Conjugate Vaccines, ... and Recombinant Vaccines. Attenuated live vaccines are derived ... which have been weakend under laboratory conditions. Conjugate ...
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
(Date:4/18/2017)... Viverae ® , a leader in workplace wellness technology, ... Watson Campaign Automation, implementing behavioral messaging within the ... experience. Through digital engagement, the platform prompts members to ... The enhanced experience drives engagement by focusing on the ... in their journey to health. Unlike ...
Breaking Medicine Technology: